88 related articles for article (PubMed ID: 2022990)
1. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
[TBL] [Abstract][Full Text] [Related]
2. Applicability of short-lived radiometallic nuclide for high sensitivity two-site "sandwich" immunoradiometric assay: human growth hormone assay.
Horiuchi K; Lin LH; Fujibayashi Y; Borghi VC; Yokoyama A
Ann Nucl Med; 1996 Feb; 10(1):49-55. PubMed ID: 8814727
[TBL] [Abstract][Full Text] [Related]
3. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
4. Development of Ga-67 labeled DFO-DAS-fibrinogen conjugate as a thrombus imaging agent.
Yamaoka S
Radiat Med; 1987; 5(5):151-3. PubMed ID: 3438481
[TBL] [Abstract][Full Text] [Related]
5. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.
Yokoyama A; Ohmomo Y; Horiuchi K; Saji H; Tanaka H; Yamamoto K; Ishii Y; Torizuka K
J Nucl Med; 1982 Oct; 23(10):909-14. PubMed ID: 7119886
[TBL] [Abstract][Full Text] [Related]
6. Ga-labeling of immunoglobulin G with high specific radioactivity.
Furukawa T; Fujibayashi Y; Fukunaga M; Yokoyama A
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2285-6. PubMed ID: 2279293
[TBL] [Abstract][Full Text] [Related]
7. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit].
Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and comparative biodistribution of the desferrioxamine-human serum albumin (DF-HSA) conjugates prepared with various methods.
Jánoki GA; Harwig JF; Wolf W
J Nucl Med Allied Sci; 1988; 32(1):39-44. PubMed ID: 3404264
[No Abstract] [Full Text] [Related]
9. Preparation of 67Ga-labelled human IgG and its Fab fragments using desferoxamine as chelating agent.
Motta-Hennessy C; Eccles SA; Dean C; Coghlan G
Eur J Nucl Med; 1985; 11(6-7):240-5. PubMed ID: 4076230
[TBL] [Abstract][Full Text] [Related]
10. Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates.
Govindan SV; Michel RB; Griffiths GL; Goldenberg DM; Mattes MJ
Nucl Med Biol; 2005 Jul; 32(5):513-9. PubMed ID: 15982582
[TBL] [Abstract][Full Text] [Related]
11. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
Brown JE; Thuy LP; Carton CL; Hougie C
J Lab Clin Med; 1983 May; 101(5):793-805. PubMed ID: 6403639
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of Ga-67 DFO-DAS-fibrinogen.
Yamamoto K; Torizuka K
Radiat Med; 1987; 5(5):180-2. PubMed ID: 3438488
[TBL] [Abstract][Full Text] [Related]
13. Arterial and venous thrombus imaging using Ga-67 DFO-DAS-fibrinogen: its clinical applicability.
Suzuki T; Torizuka K; Horiuchi K; Yokoyama A
Radiat Med; 1987; 5(5):154-8. PubMed ID: 3438483
[TBL] [Abstract][Full Text] [Related]
14. Positive imaging of venous thrombi and thromboemboli with Ga-67 DFO-DAS-fibrinogen.
Yamamoto K; Senda M; Fujita T; Kumada K; Fukui K; Yonekura Y; Yokoyama A; Torizuka K
Eur J Nucl Med; 1988; 14(2):60-4. PubMed ID: 3391213
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of Ga-67 DFO-DAS-fibrinogen.
Sasaki Y; Inoue T; Noguchi M; Kawamura Y; Uchida K; Watanuki T
Radiat Med; 1987; 5(5):170-4. PubMed ID: 3438486
[TBL] [Abstract][Full Text] [Related]
16. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
[TBL] [Abstract][Full Text] [Related]
17. Human sarcoma-associated murine monoclonal antibody labeled with indium-111, gallium-67, and iodine-125.
Bartal AH; Lavie E; Boazi M; Weininger J; Bitton M; Iosilevsky G; Front D; Hirshaut Y; Robinson E
NCI Monogr; 1987; (3):153-5. PubMed ID: 3821913
[TBL] [Abstract][Full Text] [Related]
18. Preparation and properties of antitumor monoclonal antibodies labeled with metallic radionuclides indium-111, gallium-67, and technetium-99m.
Endo K; Sakahara H; Nakashima T; Koizumi M; Ohta H; Kawamura Y; Kunimatsu M; Furukawa T; Ohmomo Y; Arano Y
NCI Monogr; 1987; (3):135-40. PubMed ID: 3469526
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
Hashmi M; Rosebrough SF
Drug Metab Dispos; 1995 Dec; 23(12):1362-7. PubMed ID: 8689944
[TBL] [Abstract][Full Text] [Related]
20. Reactions of immunoglobulin G-binding ligands with platelets and platelet-associated immunoglobulin G.
Rosse WF; Devine DV; Ware R
J Clin Invest; 1984 Feb; 73(2):489-96. PubMed ID: 6699173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
